Christine Spitzweg
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospective Study.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 03, 2026
Thyroid Nodules Seen on Ultrasound - Clinically Interpreting This Common Incidental Finding
Journal: MMW Fortschritte der Medizin
Published: July 09, 2026
Comparative assessment of KDIGO and CTCAE criteria for detecting renal function deterioration after peptide receptor radionuclide therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 24, 2026
Krenning score enhances integrated biomarker models for survival prediction in PRRT-treated GEP-NET: a retrospective cohort study.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: May 15, 2026
Outcome Of First-Line Chemotherapy For Anaplastic Thyroid Cancer - A Multicenter Registry Analysis.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 14, 2026
Stereotactic Radiotherapy for Metastatic Anaplastic Thyroid Cancer: A Single-center Experience and Systematic Review.
Journal: In vivo (Athens, Greece)
Published: November 16, 2025
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC).
Journal: Journal of cancer research and clinical oncology
Published: October 21, 2025
Correction: Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.
Journal: Targeted oncology
Published: August 27, 2025
[18F]SiTATE PET for PRRT selection and monitoring metastatic tumors of the adrenal medulla and extra-adrenal paraganglia.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 22, 2025
Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE and Monitoring with Somatostatin Receptor PET/CT in Patients with Advanced Differentiated Thyroid Carcinoma.
Journal: Molecular imaging and biology
Published: June 02, 2025
Last Updated: 09/26/2026